Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma
This study is ongoing, but not recruiting participants.
Study NCT01035658
Information provided by Sarah Cannon Research Institute
First Received on December 17, 2009.
Last Updated on December 11, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
